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1. Introduction 
In several animal species, the presence in the diet 
of rape-seed oil rich in erucic acid (cis-13-docosenoic) 
causes various pathological disorders, especially in the 
heart. Many workers have dealt with the morphological 
aspects of the affected organs; others with the metab- 
olic modifications brought about by the diet (reviewed 
[ 11). As erucic acid has often been considered respon- 
sible for such disorders, many studies have been made 
on the metabolism of this fatty acid. The results have 
shown that, although erucic acid was a source of 
expired carbon dioxide [2,3], it was also shortened 
into oleic acid [4-61, particularly in the liver. Until 
now, studies on metabolic onversions have been 
carried out on the entire animal [4-71, on isolated 
organs or on tissue culture [8,!9]. The purpose of this 
work was to determine in which cellular organelles, 
mitochondria or microsomes, these chain-shortening 
reactions in liver and heart occur. 
2. Materials and methods 
Livers and hearts from 200-2.50 g male Wistar 
rats were homogenized in a medium containing 
250 mM sucrose and 10 mM triethanolamine, adjusted 
to pH 7.4, with 10 mM EDTA in addition for the 
hearts. 
The homogenates were centrifuged at 800 X g for 
10 min at 0°C and the pellet was discarded. The 
mitochondria were separated at 8000 X g for 10 min 
at 0°C and washed twice. The supematant of the first 
mitochondrial sediment was centrifuged at 14 000 X g 
to eliminate an impure subcellular f action and micro- 
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somes were fractionated from the latter supematant 
at 105 000 X g for 45 min at 0°C and washed once. 
Mitochondrial and microsomal pellets were finally 
suspended in the sucrose-triethanolamine m dium 
and their protein concentrations were measured 
immediately [lo]. 
Purified potassium [ 14-14C]erucate (35 nmol) 
bound to bovine serum albumin (4 nmol) was added 
to 2 ml of each of the media as described in the tables. 
The media were preincubated for 15 min at 37°C 
before the addition of 2 mg mitochondrial or micro- 
somal protein and prior to incubation for 10 min at 
37°C. Incubations were stopped by the addition of 
10 ml 10% per&lo& acid for the study of the 
acid-soluble products or by the addition of 2 ml 
10% methanol-KOH for the analysis of total lipids. 
The measurements of labelled acid-soluble products 
(ASP) and labelled COz were performed as in [ 1 I]. 
The total lipids were saponified and the fatty acids 
were extracted as in [ 121, methylated, separated by 
gas-liquid chromatography, collected individually 
on glass wool as in [ 131 and their radioactivity was 
measured. 
3. Results and discussion 
When a medium favourable for P-oxidation was 
used, the results (table 1) show that the liver mito- 
chondria activated more erucic acid than did those 
from heart, but the % activated erucic acid &oxidized 
(ASP t CO& was higher with the latter. In spite of 
this, the calculated amounts of the cold-soluble 
molecules were higher with liver mitochondria 
(4.8 nmol) than with heart mitochondria (3.3 nmol). 
165 
Volume 93, number 1 FEBS LETTERS September 1978 
Table 1 
Amounts of erucic’acid activated by CoAa and percentageb transformed into oleic acid 
(18:l) or recovered as acid-soluble products (ASP) and CO, in a mediumC favourable 
for P-oxidation 
Liver Heart 
nmol activated 
erucic acidd 
Mitochondria Microsomes Mitochondria Microsomes 
12.12 2.71 5.54 0.32 
Percent 
I 
18:l 0.39 0.76 0.74 0 
found in ASP + CO, 39.68 0 60.43 0 
a Comprises erucoylCoA recovered, unacted or transformed, as long chain acylCoA and 
acylcamitines insoluble in aqueous perchloric acid, or oxidized in acid-soluble products 
and CO, 
b Percentage of the activated erucic acid 
c The incubation medium contained: 10 mM Tris-HQ buffer, pH 7.4; 35 mM KCI; 10 mM 
inorganic phosphate; 4 mM MgCl,; 1 mM ATP; 0.02 mM CoA; 2 mM DLcamitine; 1 mM 
sodium malate 
d Produced in the presence of 35 nmol [ 14-‘4C]erucic acid and 2 mg mitochondrial or 
microsomal protein 
The microsomes of liver and heart were incapable of 
producing smaller molecules from erucate. In all 
cases the radioactive oleate recovered from the 
medium in presence of mitochondria or microsomes 
was very low and almost negligible. The P-oxidation 
reactions eem thus to proceed without any forma- 
tion of intermediates. However the formation of 
shorter monoenes cannot be excluded since these 
Table 2 
Amounts of erucic acid activated by CoAa and percentageb recovered in eicosenoic acid 
(20:1), oleic acid (18:1), hexadecenoic acid (16:l) and in the acidsoluble products (ASP), 
in a mediumC favourable for chain-shortening 
Liver Heart 
Mitochondria Microsomes Mitochondria Microsomes 
nmol activated 
erucic acidd 13.65 4.11 2.02 0.37 
2O:l 5.97 2.38 7.13 
percent 18:l 1.35 0.29 5.41 e 
found in 16:l 0.42 0.28 2.87 
ASP 4.73 0.37 0.37 0 
apb Seeaandbintablel 
C The incubation medium contained: 33 mM KCl; 50 mM Pi, pH 7.6;4 mM MgCl,; 
d 
1 mM ATP; 0.05 mM CoA; 2 mM NaHCO,; 1 mM NADP; 1 mM KCN 
Produced in the presence of 35 nmol [ 14-*‘C]erucic acid and 2 mg mitochondrial or 
microsomal protein 
e Activation and shortening did not occur to a sufficient extent to give any signiicant 
fires 
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Table 3 
Amounts of erucic acid activated by CoAa and percentageb 
recovered in eicosenoic acid (20:1), oleic acid (18:1), 
hexadecenoic acid (16 : 1) and in the acidsoluble products 
(ASP), after shorteningC by liver mitochondriae 
Shortening medium 
NADP 1 mM - + - + 
DLCamitine 2 mM - - + + 
nmol activated 
erucic acidd 13.51 12.86 17.57 17.65 
I 
2O:l 2.12 12.33 7.56 11.78 
Percent 18:l 0.70 5.70 4.83 5.41 
found in 16:l 0.30 3.87 5.88 3.71 
ASP 8.00 6.86 5.48 3.45 
a, b, c, d See a-d in table 2 
e The mitochondria were incubated 15 mm at 35’C 
newly formed acids could be rapidly oxidized and 
thus could not accumulate. 
In the second series of experiments, attemps were 
made to determine whether chain-shortening was the 
reverse of the elongating reaction. Thus, oxidation 
was stopped by the addition of cyanide, and the 
absence of carnitine prevented the penetration of 
fatty acids into mitochondria nd prevented also a 
possible accumulation of acylcamitines. NADP was 
used in place of NADPH, the latter being necessary 
for the reducing reactions of elongation [121. Under 
these conditions (table 2) the radioactivity of the 
acid-soluble products was very low in each case, but 
contrary to that observed previously, monounsaturated 
fatty acids shorter than erucic acid appeared in the 
medium, mainly after incubation with mitochondria. 
Those were eicosenoic acid (20: 1 n-9) oleic acid 
(18: 1 n-9) and hexadecenoic (16: 1 n-9). 
From these two series of experiments, it appears 
that the chain-shortening of erucic acid neither follows 
the same pathway of intramitochondrial &oxidation, 
nor probably that of the reverse reaction of elongation, 
since microsomes which can actively elongate, cannot 
shorten erucic acid to the same xtent as mitochondria. 
This suggests he existence of a specific chain-shorten- 
ing system essentially ocalized in mitochondria, those 
from liver being particularly active if we consider 
their very great possibilities of activation. In absence 
of camitine, erucic acid cannot be transported across 
the inner mitochondrial membrane, which, in addi- 
tion, is impermeable to NADP. It can therefore be 
deduced that the chain-shortening system is not 
localized within the inner mitochondrial membrane, 
nor inside the mitochondria. 
The chain-shortening reaction using NADP, may 
not be the only pathway of producing shorter 
monoenes from erucic acid. In particular these 
monoenes could appear in the fust steps of the 
intramitochondrial P-oxidation, when cyanide is 
added. To test this hypothesis, athird series of 
experiments was undertaken with mitochondria 
incubated in presence of NADP or not and in 
presence of carnitine or not. Mitochondria isolated 
from liver were prefered, because they revealed the 
most active chain-shortening process in vitro and 
because in vivo 18: 1 was found in liver [6]. The 
results (table 3) show that in the absence of camitine 
the chain-shortening reaction was significant only 
when NADP was added. However the addition of 
carnitine to the incubation medium, in absence of 
NADP, increased the amount of shortened fatty 
acids. They were probably formed at the beginning 
of the P-oxidation reactions, according to the con- 
clusions in [ 141 when the respiratory chain is inhib- 
ited. When both NADP and camitine were added, 
it might be expected that the two chain-shortening 
processes would take place simultaneously. However 
the very low radioactivity of the acid-soluble pro- 
ducts suggests hat carnitine played no major part, 
in this case, facilitating the entry of erucic acid into 
the mitochondria towards the sites of P-oxidation. 
On the other hand, as the relative proportion of the 
three shortened fatty acids was the same, in the pres- 
ence of NADP alone or associated with camitine, 
and different from those observed in the presence of 
carnitine alone, it seems that erucic acid activated 
by CoA was channeled mainly towards hortening 
reactions, to the detriment of transfer eactions into 
the mitochondria. This suggests hat the chain- 
shortening system is more likely to be localized at 
the outer mitochondrial membrane; this view is 
supported by results obtained with isolated liver cells 
t91. 
The hypothesis that erucic acid could be used by 
the cardiac ells after chain-shortening, suggested in
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[ 81, is supported by the results in table 2, since the 
conversion of 20: 1 to 18 : 1 and then to 16 : 1 seems 
to be achieved more easily with heart mitochond~a 
than with those of liver. 
Proof that erucic acid is very actively shortened 
in the presence of NADP by liver and heart mito- 
chondria is presented in this paper. 
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